Combination Therapy With Ustekinumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis

There are currently no reports on the efficacy and safety of combination therapy with ustekinumab (UST) plus intensive granulocyte and monocyte adsorptive apheresis (GMA) for the treatment of refractory ulcerative colitis (UC). We retrospectively evaluated the 10-week effectiveness of combination th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanida, Satoshi, Ozeki, Keiji, Kanno, Takuya, Katano, Takahito, Sugimura, Naomi, Nishie, Hirotada, Iwasaki, Hiroyasu, Tanaka, Mamoru, Shimura, Takaya, Kubota, Eiji, Kataoka, Hiromi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670766/
https://www.ncbi.nlm.nih.gov/pubmed/34925662
http://dx.doi.org/10.14740/jocmr4625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670766/
https://www.ncbi.nlm.nih.gov/pubmed/34925662
http://dx.doi.org/10.14740/jocmr4625

Ejemplares similares